F&O picks: Biocon shows strength on charts, adopt Bull Spread: Nandish Shah

F&O strategy: Short-term trend of the Midcp Nifty turned weak, while it is strong for Biocon

The 5 Best New Cryptos to Diversify Your Portfolio in 2023 and Beyond
F&O strategy: Short-term trend of the Midcp Nifty turned weak
Nandish Shah Mumbai
2 min read Last Updated : Jun 13 2025 | 11:07 AM IST

Derivative strategy

Bear Spread strategy on Midcp Nifty

1) Buy Midcp Nifty (26-June Expiry) 13,000 Put at ₹174 and simultaneously sell 12,800 Put at ₹107
 
  • Lot size: 120
  • Cost of the strategy: ₹67 (₹8,040 per strategy)
  • Maximum profit: ₹15,960, if Midcp Nifty closes at or below 12,800 on 26 June expiry.
  • Breakeven point: ₹12,933
  • Risk reward ratio: 1: 2.0
  • Approx margin required: ₹31,000
 
Rationale:
 
  • Long unwinding is seen in the Midcp Nifty futures, where we have seen 2 per cent fall in open interest with it falling by 1.5 per cent.
  • Short term trend of the Index turned weak as it has closed below its 5 day EMA.
  • Index formed double top pattern around 13,400 levels and reversed southwards on daily chart.
  • Midcp Nifty Put Call ratio came down to 0.95 levels from 1.06 on the back of aggressive call writing at 13,000-13,200 levels.
Track LIVE Stock Market Updates Here 

2) Bull Spread strategy on Biocon

Buy Biocon (26-June Expiry) 355 Call at ₹7.20 and simultaneously sell 370 Call at ₹2.80
 
  • Lot size: 2,500
  • Cost of strategy: ₹4.40 (₹11,000 per strategy)
  • Maximum profit: ₹26,500, if Biocon closes at or above ₹370 on 26 June expiry.
  • Breakeven point: ₹359.4
  • Risk reward ratio: 1: 2.41
  • Approx margin required: ₹31,000
 
Rationale:
 
  • Long build up is seen in the Biocon Futures, where we have seen 17 per cent rise in open interest during the June series till now with price rising by 5 per cent.
  • Short term trend of the stock is strong, as the stock price is placed above its 5,11 and 20 day EMA.
  • Biocon Stock price has broken out on the daily chart with higher volumes.
  • RSI oscillator is in rising mode and placed above 60 on the daily chart, indicating strength in the current uptrend.
 
(Disclaimer: This article is by Nandish Shah, senior technical/derivative analyst at HDFC Securities. Views expressed are his own.) 
 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :MarketsTechinical callsStock callsDerivative tradingDerivatives strategyEquity derivativesStocks in focusBioconNifty midcap

First Published: Jun 13 2025 | 7:33 AM IST

Next Story